Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 3.36% | 75.30 | 1.0% | $2155.98m | |
| AMGN | Amgen, Inc. | 3.83% | 205.86 | 1.3% | $947.68m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 5.44% | 473.99 | 2.6% | $817.76m | |
| BIIB | Biogen, Inc. | 7.22% | 318.17 | 1.5% | $763.25m | |
| MRNA | Moderna, Inc. | 0.42% | 30.18 | 0.0% | $642.98m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 6.65% | 231.68 | 1.9% | $561.91m | |
| ILMN | Illumina, Inc. | 1.55% | 273.22 | 3.5% | $490.16m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 3.45% | 86.91 | 2.0% | $274.94m | |
| A | Agilent Technologies, Inc. | 1.64% | 71.89 | 1.6% | $240.38m | |
| EXAS | EXACT Sciences Corp. | 0.92% | 58.43 | 21.0% | $207.35m | |
| INCY | Incyte Corp. | 3.13% | 71.12 | 2.5% | $172.79m | |
| SGEN | Seattle Genetics, Inc. | 4.34% | 114.01 | 6.1% | $169.33m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 3.60% | 82.37 | 4.3% | $166.12m | |
| NVAX | Novavax, Inc. | 8.89% | 14.21 | 114.7% | $163.28m | |
| CODX | Co-Diagnostics, Inc. | -10.27% | 8.21 | 0.0% | $133.25m |
Company Profile
Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.